RIC1

RIC1 forms an obligate complex with RGP1 that functions as the guanine nucleotide exchange factor (GEF) for the late Golgi Rab6A GTPase; both subunits are required for nucleotide exchange activity, and loss of RIC1 destabilizes Rab6 and blocks Rab6-dependent retrograde transport of mannose 6-phosphate receptors to the Golgi (PMID:23091056). The RIC1–RGP1 complex activates Rab6 through a helical RabGEF domain that engages the Rab6 nucleotide-binding pocket, while an arrestin fold contacts the Rab6 hypervariable tail, as revealed by cryo-EM structure determination and validated by mutagenesis (PMID:39632878). The C-terminus of RIC1 additionally binds active Rab33B-GTP, establishing a Rab cascade that links medial-Golgi identity to trans-Golgi Rab6 activation (PMID:23091056). In vivo, RIC1 is required for Golgi-dependent collagen secretion during skeletal development, as demonstrated by craniofacial defects and collagen trafficking failure in zebrafish ric1 mutants (PMID:31932796).

1. 2010 Medium

   Establishing that Ric1 operates in the same functional pathway as the Rab6 ortholog Ryh1: genetic epistasis in fission yeast showed that Ric1 loss phenocopies Ryh1 loss and prevents Ryh1 Golgi/endosome localization, positioning Ric1 as the upstream activator of this Rab GTPase.

   Evidence Genetic epistasis (double knockout), localization imaging, and high-copy suppressor analysis in S. pombe

   PMID:20623139

   Open questions at the time

   • Biochemical GEF activity was not directly demonstrated in this system
   • Whether fission yeast Ric1 requires an Rgp1-like partner was not tested
2. 2012 High

   Resolving the molecular activity of human RIC1: the RIC1–RGP1 complex was shown to be the bona fide GEF for Rab6A, with both subunits required for nucleotide exchange, and RIC1 loss was shown to block retrograde mannose 6-phosphate receptor trafficking, defining the functional consequence in human cells. The same study identified a Rab33B-GTP binding site on the RIC1 C-terminus, establishing a Rab cascade model linking medial- and trans-Golgi compartments.

   Evidence Co-immunoprecipitation, in vitro nucleotide exchange assay, GDP-preference binding assay, siRNA knockdown with retrograde transport readout, and pull-down with nucleotide-loaded Rab33B in human cells

   PMID:23091056

   Open questions at the time

   • Structural basis for Rab6 activation was unknown
   • The Rab33B binding site was mapped to the RIC1 C-terminus but atomic contacts were undefined
   • Whether RIC1 has additional Rab substrates was not addressed
3. 2020 Medium

   Demonstrating organismal-level function: loss of ric1 in zebrafish caused craniofacial and skeletal defects traceable to defective collagen secretion from the Golgi, establishing an in vivo requirement for RIC1-mediated Rab6 activation in secretory cargo trafficking during development.

   Evidence Zebrafish genetic screen with ric1 mutants, phenotypic rescue, and collagen secretion assays

   PMID:31932796

   Open questions at the time

   • Whether collagen trafficking defects are a direct consequence of Rab6 inactivation or involve additional Rab substrates was not resolved
   • Human disease causation by RIC1 mutations was not formally demonstrated in this study
4. 2024 High

   Providing the structural mechanism: cryo-EM of the Ric1–Rgp1–Rab6 ternary complex revealed that a novel helical RabGEF domain contacts the Rab6 nucleotide-binding pocket while an arrestin fold engages the Rab6 hypervariable tail, and mutagenesis of key RabGEF residues abolished exchange activity, defining the catalytic mechanism at atomic resolution.

   Evidence Cryo-EM structure determination, site-directed mutagenesis, and in vitro nucleotide exchange assays

   PMID:39632878

   Open questions at the time

   • How Rab33B binding to the RIC1 C-terminus allosterically influences GEF activity toward Rab6 is structurally unresolved
   • The membrane-proximal orientation of the complex on Golgi membranes remains unknown

• Open question: how Rab33B-GTP binding at the RIC1 C-terminus is coupled to Rab6 activation at the RabGEF domain, whether RIC1 mutations cause human Mendelian disease, and whether the RIC1–RGP1 complex activates Rabs beyond Rab6A remain unresolved.
• Allosteric coupling between Rab33B-binding and Rab6-GEF domains is structurally uncharacterized
• No causal human genetic disease has been formally linked to RIC1 mutations in the primary literature captured here
• Substrate specificity beyond Rab6A has not been systematically tested